Cytoplasmic microtubular dynamics and chromatin organization during mammalian oogenesis and oocyte maturation.

D. Albertini

DOI: https://doi.org/10.1016/0165-1110(92)90032-5

1992-12-01

Mutation Research

Abstract:

What problem does this paper attempt to address?

Exercise‐Based Cardiac Rehabilitation for Very Old Patients (≥75 Years): FOCUS ON PHYSICAL FUNCTION

M. Audelin,P. Savage,P. Ades

DOI: https://doi.org/10.1097/01.HCR.0000320066.58599.e5

2008-05-01

Journal of Cardiopulmonary Rehabilitation and Prevention

Abstract:Older patients have high rates of physical function impairment and disability following a cardiac event. Exercise training has been shown to favorably affect such limitations, as well as cardiovascular risk factors, symptoms, and mortality postcoronary event in middle-aged patients. Aerobic capacity, body strength, quality of life, and physical function are improved with exercise-based cardiac rehabilitation (CR) in patients older than 65 years. However, there have been relatively few studies of the effects of exercise-based CR on physical function recovery in the very oldpatients (≥75 years), despite the continuous growth of this segment of thepopulation. After hospitalization for a cardiac event, postacute inpatient CR serves as a bridge between acute care and independent home living for the most disabled older patients. It plays an important role in the physical recovery process, particularly after cardiac surgery. Exercise-based outpatient (phase II) CR, starting early after hospital discharge, is safe in very old patients and studies demonstrate that these patients derive similar benefits from CR, compared with younger patients, regarding physical function improvement. Older patients, however, are less likely than younger cardiac patients to participate in outpatient CR programs. There is a need to find protocols that could increase the referral and participation rates of the frailer and older cardiac patient to exercise-based CR.
The MLKL Channel in Necroptosis is an Octamer Formed by Tetramers in a Dyadic Process.

Deli Huang,Xinru Zheng,Zi-an Wang,Xin Chen,Wan-ting He,Yingying Zhang,Jin-Gen Xu,Hang Zhao,Wenke Shi,Xin Wang,Yongqun Zhu,Jiahuai Han

DOI: https://doi.org/10.1128/mcb.00497-16

IF: 5.069

2016-01-01

Molecular and Cellular Biology

Abstract:Oligomerization of the mixed-lineage kinase domain-like protein (MLKL) is essential for its cation channel function in necroptosis. Here we show that the MLKL channel is an octamer comprising two previously identified tetramers most likely in their side-by-side position. Intermolecule disulfide bonds are present in the tetramer but are not required for octamer assembly and necroptosis. MLKL forms oligomers in the necrosome and is then released from the necrosome before or during its membrane translocation. We identified two MLKL mutants that could not oligomerize into octamers, although they formed a tetramer, and also, one MLKL mutant could spontaneously form a disulfide bond-linked octamer. Subsequent analysis revealed that the tetramers fail to translocate to the plasma membrane and that the MLKL octamer formation depends on α-helices 4 and 5. While MLKL could be detected from outside the cells, its N- and C-terminal ends could not be detected, indicating that the MLKL octamer spans across the plasma membrane, leaving its N and C termini inside the cell. These data allowed us to propose a 180° symmetry model of the MLKL octamer and conclude that the fully assembled MLKL octamers, but not the previously described tetramers, act as effectors of necroptosis.
Motor skills bibliography: 33. Psychological Abstracts, 1958, Volume 32, second half.

C. H. Ammons,R. Ammons

Perceptual and Motor Skills

Abstract:
Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

Yanxiang Meng,Sarah E Garnish,Katherine A Davies,Katrina A Black,Andrew P Leis,Christopher R Horne,Joanne M Hildebrand,Hanadi Hoblos,Cheree Fitzgibbon,Samuel N Young,Toby Dite,Laura F Dagley,Aarya Venkat,Natarajan Kannan,Akiko Koide,Shohei Koide,Alisa Glukhova,Peter E Czabotar,James M Murphy

DOI: https://doi.org/10.1038/s41467-023-42255-w

2023-10-26

Abstract:The necroptosis pathway is a lytic, pro-inflammatory mode of cell death that is widely implicated in human disease, including renal, pulmonary, gut and skin inflammatory pathologies. The precise mechanism of the terminal steps in the pathway, where the RIPK3 kinase phosphorylates and triggers a conformation change and oligomerization of the terminal pathway effector, MLKL, are only emerging. Here, we structurally identify RIPK3-mediated phosphorylation of the human MLKL activation loop as a cue for MLKL pseudokinase domain dimerization. MLKL pseudokinase domain dimerization subsequently drives formation of elongated homotetramers. Negative stain electron microscopy and modelling support nucleation of the MLKL tetramer assembly by a central coiled coil formed by the extended, ~80 Å brace helix that connects the pseudokinase and executioner four-helix bundle domains. Mutational data assert MLKL tetramerization as an essential prerequisite step to enable the release and reorganization of four-helix bundle domains for membrane permeabilization and cell death.
Adrenalectomy for advanced breast cancer: a reappraisal.

A. G. Paterson,D. Webster

Anticancer Research

Abstract:The introduction of strict criteria of treatment response for advanced breast cancer facilitates comparison of treatment modalities. Recent studies of pharmacological measures are usually recorded according to UICC criteria but this has not been the case with regard to adrenalectomy. An analysis of 41 patients undergoing adrenalectomy for advanced breast cancer was undertaken to assess response according to UICC criteria. There were no complete objective responses but 12.2% had Partial Remission and 12.2% Static Disease, the remainder showing disease progression. These figures are lower than in most reported series which have used less clearly defined criteria of response. The Partial Response and No Change groups were similar in terms of symptomatic improvement and survival but superior to the treatment failure group. Adrenalectomy was associated with significant morbidity (46.7%) and operative mortality (6.7%). Only 1 patient of 11 previously treated with tamoxifen had a subsequent response to adrenalectomy. The low response rate when assessed on UICC criteria and high morbidity when compared with alternative treatment suggest that adrenalectomy will be less widely used in the future.
Ureide ring scission of phenobarbital by sodium borohydride.

L. Chafetz,T. Chen,R. Greenough

DOI: https://doi.org/10.1002/JPS.2600620341

1973-03-01

Journal of Pharmacy and Science

Abstract:
Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Dan E McNamara,Giovanni Quarato,Cliff S Guy,Douglas R Green,Tudor Moldoveanu

DOI: https://doi.org/10.3791/58088

2018-08-07

Abstract:Necroptosis is a programmed cell death pathway triggered by activation of receptor interacting protein kinase 3 (RIPK3), which phosphorylates and activates the mixed lineage kinase-like domain pseudokinase, MLKL, to rupture or permeabilize the plasma membrane. Necroptosis is an inflammatory pathway associated with multiple pathologies including autoimmunity, infectious and cardiovascular diseases, stroke, neurodegeneration, and cancer. Here, we describe protocols that can be used to characterize MLKL as the executioner of plasma membrane rupture in necroptosis. We visualize the process of necroptosis in cells using live-cell imaging with conventional and confocal fluorescence microscopy, and in fixed cells using electron microscopy, which together revealed the redistribution of MLKL from the cytosol to the plasma membrane prior to induction of large holes in the plasma membrane. We present in vitro nuclear magnetic resonance (NMR) analysis using lipids to identify putative modulators of MLKL-mediated necroptosis. Based on this method, we identified quantitative lipid-binding preferences and phosphatidyl-inositol phosphates (PIPs) as critical binders of MLKL that are required for plasma membrane targeting and permeabilization in necroptosis.
[Interhemispheric differences and the interaction of the hemispheres].

N. Otmakhova,V. Konovalov

Успехи физиологических наук

Abstract:
The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis

Katherine A Davies,Maria C Tanzer,Michael D W Griffin,Yee Foong Mok,Samuel N Young,Rui Qin,Emma J Petrie,Peter E Czabotar,John Silke,James M Murphy

DOI: https://doi.org/10.1038/s41418-018-0061-3

Abstract:The programmed cell death pathway, necroptosis, relies on the pseudokinase, Mixed Lineage Kinase domain-Like (MLKL), for cellular execution downstream of death receptor or Toll-like receptor ligation. Receptor-interacting protein kinase-3 (RIPK3)-mediated phosphorylation of MLKL's pseudokinase domain leads to MLKL switching from an inert to activated state, where exposure of the N-terminal four-helix bundle (4HB) 'executioner' domain leads to cell death. The precise molecular details of MLKL activation, including the stoichiometry of oligomer assemblies, mechanisms of membrane translocation and permeabilisation, remain a matter of debate. Here, we dissect the function of the two 'brace' helices that connect the 4HB to the pseudokinase domain of MLKL. In addition to establishing that the integrity of the second brace helix is crucial for the assembly of mouse MLKL homotrimers and cell death, we implicate the brace helices as a device to communicate pseudokinase domain phosphorylation event(s) to the N-terminal executioner 4HB domain. Using mouse:human MLKL chimeras, we defined the first brace helix and adjacent loop as key elements of the molecular switch mechanism that relay pseudokinase domain phosphorylation to the activation of the 4HB domain killing activity. In addition, our chimera data revealed the importance of the pseudokinase domain in conferring host specificity on MLKL killing function, where fusion of the mouse pseudokinase domain converted the human 4HB + brace from inactive to a constitutive killer of mouse fibroblasts. These findings illustrate that the brace helices play an active role in MLKL regulation, rather than simply acting as a tether between the 4HB and pseudokinase domains.
Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis

Yanxiang Meng,Katherine A. Davies,Cheree Fitzgibbon,Samuel N. Young,Sarah E. Garnish,Christopher R. Horne,Cindy Luo,Jean-Marc Garnier,Lung-Yu Liang,Angus D. Cowan,Andre L. Samson,Guillaume Lessene,Jarrod J. Sandow,Peter E. Czabotar,James M. Murphy

DOI: https://doi.org/10.1038/s41467-021-27032-x

IF: 16.6

2021-11-22

Nature Communications

Abstract:Abstract The ancestral origins of the lytic cell death mode, necroptosis, lie in host defense. However, the dysregulation of necroptosis in inflammatory diseases has led to widespread interest in targeting the pathway therapeutically. This mode of cell death is executed by the terminal effector, the MLKL pseudokinase, which is licensed to kill following phosphorylation by its upstream regulator, RIPK3 kinase. The precise molecular details underlying MLKL activation are still emerging and, intriguingly, appear to mechanistically-diverge between species. Here, we report the structure of the human RIPK3 kinase domain alone and in complex with the MLKL pseudokinase. These structures reveal how human RIPK3 structurally differs from its mouse counterpart, and how human RIPK3 maintains MLKL in an inactive conformation prior to induction of necroptosis. Residues within the RIPK3:MLKL C-lobe interface are crucial to complex assembly and necroptotic signaling in human cells, thereby rationalizing the strict species specificity governing RIPK3 activation of MLKL.

multidisciplinary sciences
Necrosome core machinery: MLKL

Jing Zhang,Yu Yang,Wenyan He,Liming Sun

DOI: https://doi.org/10.1007/s00018-016-2190-5

IF: 8

2016-04-05

Cellular and Molecular Life Sciences

Abstract:In the study of regulated cell death, the rapidly expanding field of regulated necrosis, in particular necroptosis, has been drawing much attention. The signaling of necroptosis represents a sophisticated form of a death pathway. Anti-caspase mechanisms (e.g., using inhibitors of caspases, or genetic ablation of caspase-8) switch cell fate from apoptosis to necroptosis. The initial extracellular death signals regulate RIP1 and RIP3 kinase activation. The RIP3-associated death complex assembly is necessary and sufficient to initiate necroptosis. MLKL was initially identified as an essential mediator of RIP1/RIP3 kinase-initiated necroptosis. Recent studies on the signal transduction using chemical tools and biomarkers support the idea that MLKL is able to make more functional sense for the core machinery of the necroptosis death complex, called the necrosome, to connect to the necroptosis execution. The experimental data available now have pointed that the activated MLKL forms membrane-disrupting pores causing membrane leakage, which extends the prototypical concept of morphological and biochemical events following necroptosis happening in vivo. The key role of MLKL in necroptosis signaling thus sheds light on the logic underlying this unique “membrane-explosive” cell death pathway. In this review, we provide the general concepts and strategies that underlie signal transduction of this form of cell death, and then focus specifically on the role of MLKL in necroptosis.

cell biology,biochemistry & molecular biology
Pregnancy outcome after suicide attempt by drug use: a Danish population‐based study

C. Flint,H. Larsen,G. L. Nielsen,J. Olsen,Henrik T Sørensen

DOI: https://doi.org/10.1034/j.1600-0412.2002.810607.x

2002-06-01

Acta Obstetricia Et Gynecologica Scandinavica

Abstract:Background. It is important to study the side‐effects of drugs taken during pregnancy, however the findings are difficult to interpret because of a low exposure level, uncertainty of actual drug consumption and confounding by indication. Experience from accidental or intended drug intoxications may bypass some of these methodological shortcomings. Our aim was to examine reproductive failures and child health following a single drug overdose taken prior to or during pregnancy.
Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

Huayi Wang,Liming Sun,Lijing Su,Josep Rizo,Lei Liu,Li-Feng Wang,Fu-Sheng Wang,Xiaodong Wang

DOI: https://doi.org/10.1016/j.molcel.2014.03.003

IF: 16

2014-01-01

Molecular Cell

Abstract:Programmed necrotic cell death induced by the tumor necrosis factor alpha (TNF-α) family of cytokines is dependent on a kinase cascade consisting of receptor-interacting kinases RIP1 and RIP3. How these kinase activities cause cells to die by necrosis is not known. The mixed lineage kinase domain-like protein MLKL is a functional RIP3 substrate that binds to RIP3 through its kinase-like domain but lacks kinase activity of its own. RIP3 phosphorylates MLKL at the T357 and S358 sites. Reported here is the development of a monoclonal antibody that specifically recognizes phosphorylated MLKL in cells dying of this pathway and in human liver biopsy samples from patients suffering from drug-induced liver injury. The phosphorylated MLKL forms an oligomer that binds to phosphatidylinositol lipids and cardiolipin. This property allows MLKL to move from the cytosol to the plasma and intracellular membranes, where it directly disrupts membrane integrity, resulting in necrotic death.
The Many Faces of MLKL, the Executor of Necroptosis

Veronica Martinez-Osorio,Yasmin Abdelwahab,Uris Ros

DOI: https://doi.org/10.3390/ijms241210108

IF: 5.6

2023-06-14

International Journal of Molecular Sciences

Abstract:Necroptosis is a recently discovered form of regulated cell death characterized by the disruption of plasma membrane integrity and the release of intracellular content. Mixed lineage kinase domain-like (MLKL) protein is the main player of this cell death pathway as it mediates the final step of plasma membrane permeabilization. Despite the significant progress in our knowledge of the necroptotic pathway and MLKL biology, the precise mechanism of how MLKL functions remain unclear. To understand in what way MLKL executes necroptosis, it is crucial to decipher how the molecular machinery of regulated cell death is activated in response to different stimuli or stressors. It is also indispensable to unveiling the structural elements of MLKL and the cellular players that are required for its regulation. In this review, we discuss the key steps that lead to MLKL activation, possible models that explain how it becomes the death executor in necroptosis, and its emerging alternative functions. We also summarize the current knowledge about the role of MLKL in human disease and provide an overview of existing strategies aimed at developing new inhibitors that target MLKL for necroptosis intervention.

biochemistry & molecular biology,chemistry, multidisciplinary
Acylation of MLKL Impacts Its Function in Necroptosis

Apoorva J. Pradhan,Shweta Chitkara,Ricardo X. Ramirez,Viviana Monje-Galvan,Yasemin Sancak,G. Ekin Atilla-Gokcumen

DOI: https://doi.org/10.1021/acschembio.3c00603

IF: 4.634

2024-02-02

ACS Chemical Biology

Abstract:Mixed lineage kinase domain-like (MLKL) is a key signaling protein of necroptosis. Upon activation by phosphorylation, MLKL translocates to the plasma membrane and induces membrane permeabilization, which contributes to the necroptosis-associated inflammation. Membrane binding of MLKL is initially initiated by electrostatic interactions between the protein and membrane phospholipids. We previously showed that MLKL and its phosphorylated form (pMLKL) are S-acylated during necroptosis. Here, we...

biochemistry & molecular biology
Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

D A Rodriguez,R Weinlich,S Brown,C Guy,P Fitzgerald,C P Dillon,A Oberst,G Quarato,J Low,J G Cripps,T Chen,D R Green

DOI: https://doi.org/10.1038/cdd.2015.70

IF: 12.067

2015-05-29

Cell Death and Differentiation

Abstract:Mixed lineage kinase domain-like pseudokinase (MLKL) mediates necroptosis by translocating to the plasma membrane and inducing its rupture. The activation of MLKL occurs in a multimolecular complex (the ‘necrosome’), which is comprised of MLKL, receptor-interacting serine/threonine kinase (RIPK)-3 (RIPK3) and, in some cases, RIPK1. Within this complex, RIPK3 phosphorylates the activation loop of MLKL, promoting conformational changes and allowing the formation of MLKL oligomers, which migrate to the plasma membrane. Previous studies suggested that RIPK3 could phosphorylate the murine MLKL activation loop at Ser345, Ser347 and Thr349. Moreover, substitution of the Ser345 for an aspartic acid creates a constitutively active MLKL, independent of RIPK3 function. Here we examine the role of each of these residues and found that the phosphorylation of Ser345 is critical for RIPK3-mediated necroptosis, Ser347 has a minor accessory role and Thr349 seems to be irrelevant. We generated a specific monoclonal antibody to detect phospho-Ser345 in murine cells. Using this antibody, a series of MLKL mutants and a novel RIPK3 inhibitor, we demonstrate that the phosphorylation of Ser345 is not required for the interaction between RIPK3 and MLKL in the necrosome, but is essential for MLKL translocation, accumulation in the plasma membrane, and consequent necroptosis.

cell biology,biochemistry & molecular biology
The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling

Yu Zhang,Jia Liu,Dandan Yu,Xinxin Zhu,Xiaoyan Liu,Jun Liao,Sheng Li,Huayi Wang

DOI: https://doi.org/10.1038/s41419-021-03859-6

2021-06-22

Cell Death and Disease

Abstract:Abstract MLKL phosphorylation by RIP3 is the commitment step of necroptosis execution, which could induce MLKL activation featured as MLKL monomer-oligomer transition. Here, we reported that the dimerization of the MLKL kinase-like domain was the direct consequence of RIP3 triggered MLKL-phosphorylation. Two inter-dimer interfaces were found in the crystal structure of human MLKL. Mutations destroying both interfaces could prevent RIP3-induced MLKL oligomerization and necroptosis efficiently. Moreover, we confirmed MLKL self-assembly by the internal coiled-coil region is necessary for MLKL oligomerization and function. The mutations disrupting coiled-coil self-assembly repressed necroptosis, but it did not prevent RIP3-induced dimerization of the MLKL kinase-like domain. So that, MLKL activation is a sequential process, which begins with kinase-like domain dimerization, and followed by internal coiled-coil region self-assembly to form a proper MLKL oligomer. Besides human MLKL, structural and functional analysis showed the kinase-like domain dimerization was conserved among mammalian species, suggesting it is a general step of the RIP3-induced MLKL activation process.

cell biology
The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis

Lu Li,An Tong,Qiangsheng Zhang,Yuquan Wei,Xiawei Wei

DOI: https://doi.org/10.1093/jmcb/mjaa055

2021-04-10

Abstract:Necrosis, a type of unwanted and passive cell demise, usually occurs under the excessive external stress and is considered to be unregulated. However, under some special conditions such as caspase inhibition, necrosis is regulable in a well-orchestrated way. The term 'regulated necrosis' has been proposed to describe such programed necrosis. Recently, several forms of necrosis, including necroptosis, pyroptosis, ferroptosis, parthanatos, oxytosis, NETosis, and Na+/K+-ATPase-mediated necrosis, have been identified, and some crucial regulators governing regulated necrosis have also been discovered. Mixed lineage kinase domain-like pseudokinase (MLKL), a core regulator in necroptosis, acts as an executioner in response to ligands of death receptor family. Its activation requires the receptor-interacting protein kinases, RIP1 and RIP3. However, MLKL is only involved in necroptosis, i.e. MLKL is dispensable for necrosis. Therefore, this review is aimed at summarizing the molecular mechanisms of MLKL-dependent and MLKL-independent necrosis.
Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Wanze Chen,Zhenru Zhou,Lisheng Li,Chuan-Qi Zhong,Xinru Zheng,Xiurong Wu,Yingying Zhang,Huan Ma,Deli Huang,Wenjuan Li,Zongping Xia,Jiahuai Han

DOI: https://doi.org/10.1074/jbc.M112.435545

IF: 5.485

2013-01-01

Journal of Biological Chemistry

Abstract:Receptor interacting protein 3 (RIP3) is a protein kinase essential for TNF-induced necroptosis. Phosphorylation on Ser-227 in human RIP3 (hRIP3) is required for its interaction with human mixed lineage kinase domain-like (MLKL) in the necrosome, a signaling complex induced by TNF stimulation. RIP1 and RIP3 mediate necrosome aggregation leading to the formation of amyloid-like signaling complexes. We found that TNF induces Thr-231 and Ser-232 phosphorylation in mouse RIP3 (mRIP3) and this phosphorylation is required for mRIP3 to interact with mMLKL. Ser-232 in mRIP3 corresponds to Ser-227 in hRIP3, whereas Thr-231 is not conserved in hRIP3. Although the RIP3-MLKL interaction is required for necroptosis in both human and mouse cells, hRIP3 does not interact with mMLKL and mRIP3 cannot bind to hMLKL. The species specificity of the RIP3-MLKL interaction is primarily determined by the sequence differences in the phosphorylation sites and the flanking sequence around the phosphorylation sites in hRIP3 and mRIP3. It appears that the RIP3-MLKL interaction has been selected as an evolutionarily conserved mechanism in mediating necroptosis signaling despite that differing structural and mechanistic bases for this interaction emerged simultaneously in different organisms. In addition, we further revealed that the interaction of RIP3 with MLKL prevented massive abnormal RIP3 aggregation, and therefore should be crucial for formation of the amyloid signaling complex of necrosomes. We also found that the interaction between RIP3 and MLKL is required for the translocation of necrosomes to mitochondria-associated membranes. Our data demonstrate the importance of the RIP3-MLKL interaction in the formation of functional necrosomes and suggest that translocation of necrosomes to mitochondria-associated membranes is essential for necroptosis signaling.
Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

Xin Chen,Wenjuan Li,Junming Ren,Deli Huang,Wan-ting He,Yunlong Song,Chao Yang,Wanyun Li,Xinru Zheng,Pengda Chen,Jiahuai Han

DOI: https://doi.org/10.1038/cr.2013.171

IF: 44.1

2013-12-24

Cell Research

Abstract:Mixed lineage kinase domain-like protein (MLKL) was identified to function downstream of receptor interacting protein 3 (RIP3) in tumor necrosis factor-α (TNF)-induced necrosis (also called necroptosis). However, how MLKL functions to mediate necroptosis is unknown. By reconstitution of MLKL function in MLKL-knockout cells, we showed that the N-terminus of MLKL is required for its function in necroptosis. The oligomerization of MLKL in TNF-treated cells is essential for necroptosis, as artificially forcing MLKL together by using the hormone-binding domain (HBD*) triggers necroptosis. Notably, forcing together the N-terminal domain (ND) but not the C-terminal kinase domain of MLKL causes necroptosis. Further deletion analysis showed that the four-α-helix bundle of MLKL (1-130 amino acids) is sufficient to trigger necroptosis. Both the HBD*-mediated and TNF-induced complexes of MLKL(ND) or MLKL are tetramers, and translocation of these complexes to lipid rafts of the plasma membrane precedes cell death. The homo-oligomerization is required for MLKL translocation and the signal sequence for plasma membrane location is located in the junction of the first and second α-helices of MLKL. The plasma membrane translocation of MLKL or MLKL(ND) leads to sodium influx, and depletion of sodium from the cell culture medium inhibits necroptosis. All of the above phenomena were not seen in apoptosis. Thus, the MLKL oligomerization leads to translocation of MLKL to lipid rafts of plasma membrane, and the plasma membrane MLKL complex acts either by itself or via other proteins to increase the sodium influx, which increases osmotic pressure, eventually leading to membrane rupture.

cell biology

Cytoplasmic microtubular dynamics and chromatin organization during mammalian oogenesis and oocyte maturation.

Exercise‐Based Cardiac Rehabilitation for Very Old Patients (≥75 Years): FOCUS ON PHYSICAL FUNCTION

The MLKL Channel in Necroptosis is an Octamer Formed by Tetramers in a Dyadic Process.

Motor skills bibliography: 33. Psychological Abstracts, 1958, Volume 32, second half.

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

Adrenalectomy for advanced breast cancer: a reappraisal.

Ureide ring scission of phenobarbital by sodium borohydride.

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

[Interhemispheric differences and the interaction of the hemispheres].

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis

Necrosome core machinery: MLKL

Pregnancy outcome after suicide attempt by drug use: a Danish population‐based study

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

The Many Faces of MLKL, the Executor of Necroptosis

Acylation of MLKL Impacts Its Function in Necroptosis

Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death